Zihan Guo

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Southwest Jiaotong University · ORCID：0000-0003-4076-9386

发表论文 21 篇 · 总被引 149 次 · h-index 7

代表论文

Safety of trastuzumab deruxtecan: A meta‐analysis and pharmacovigilance study (2022 · Journal of Clinical Pharmacy and Therapeutics · 被引 36)
Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database (2023 · Frontiers in Pharmacology · 被引 33)
CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network (2024 · Frontiers in Pharmacology · 被引 21)
Real world pharmacovigilance assessment of drug related macular degeneration risks (2025 · Scientific Reports · 被引 14)
Ocular adverse events associated with BRAF and MEK inhibitor combination therapy: a pharmacovigilance disproportionality analysis of the FDA adverse event reporting system (2023 · Expert Opinion on Drug Safety · 被引 11)
Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study (2024 · Pharmaceuticals · 被引 10)